Hanne Bak - Zealand Pharma Director, Employee Representative

Director

Ms. Hanne Heidenheim Bak was appointed Director, Employee Representative at Zealand Pharma AS, effective as of April 19, 2016. She previously held that position at the Company from April 17, 2012 to April 29, 2014. She is Senior Project Director, GI, External Relations and Collaborations and she holds M.Sc. from the Danish University of Pharmaceutical Sciences. Prior to joining Zealand in 2006, Hanne H. Bak worked 8 years as Project Manager of latephase development programs at H. Lundbeck AS, followed by 9 years as Executive Director at the Lundbeck Institute. since 2016.
Age 69
Tenure 8 years
Phone45 88 77 36 00
Webhttps://www.zealandpharma.com

Zealand Pharma Management Efficiency

The company has return on total asset (ROA) of (0.3786) % which means that it has lost $0.3786 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1545) %, meaning that it created substantial loss on money invested by shareholders. Zealand Pharma's management efficiency ratios could be used to measure how well Zealand Pharma manages its routine affairs as well as how well it operates its assets and liabilities.
Zealand Pharma AS currently holds 647.91 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. Zealand Pharma AS has a current ratio of 4.69, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Zealand Pharma's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 10 records

DIRECTOR Age

Brian MariottiFunko Inc
56
Paul WhetsellBoyd Gaming
70
Robert BoughnerBoyd Gaming
67
Robert JaffeFunko Inc
N/A
Michael LunsfordFunko Inc
56
Peter ThomasBoyd Gaming
71
Veronica WilsonBoyd Gaming
68
John BaileyBoyd Gaming
60
Jessica PihaGrafsteinFunko Inc
N/A
Christine SpadaforBoyd Gaming
65
Zealand Pharma AS, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark. Zealand Pharma operates under Biotechnology classification in the United States and is traded on NMS Exchange. It employs 345 people. Zealand Pharma AS (ZEAL) is traded on NASDAQ Exchange in USA and employs 237 people.

Management Performance

Zealand Pharma AS Leadership Team

Elected by the shareholders, the Zealand Pharma's board of directors comprises two types of representatives: Zealand Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Zealand. The board's role is to monitor Zealand Pharma's management team and ensure that shareholders' interests are well served. Zealand Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Zealand Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lani Morvan, Investor Officer
Hanne Bak, Director, Employee Representative
Adam MD, Pres CEO
Mads Kronborg, Head Communication
Ravinder Chahil, Sr Counsel
Danilo Verge, Head Affairs
Christina Bredal, VP Organization
Ivan Moller, Chief Officer
Jens MD, Head Pharmacology
David MD, Chief Officer

Zealand Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Zealand Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Other Consideration for investing in Zealand Stock

If you are still planning to invest in Zealand Pharma AS check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zealand Pharma's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope